All lobbying filings

Keefe Strategies LLC FKA Keefe Singiser Partners

Keefe Strategies LLC FKA Keefe Singiser Partners filed a Q4 termination report for Mayne Pharma Commercial LLC on January 15, 2026, reporting $30,000 in lobbying income.

Lobbying for Mayne Pharma Commercial LLC · Pharmaceutical company

As filed: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS for MAYNE PHARMA COMMERCIAL LLC.

All filings by Keefe Strategies LLC FKA Keefe Singiser Partners · Everything Mayne Pharma Commercial LLC has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 15, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

North Carolina

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 1

DANA SINGISER

Previously held: Special Assistant to the President, The White House; Staff Director, Senate Democratic Steering and Outreach Committee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to coverage of pharmaceutical products

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.